touchENDOCRINOLOGY were delighted to speak to Jose Florez, Committee Chair for the ADA’s Scientific Sessions Meeting Planning Committee, about his highlights of the conference, organising such a large virtual platform, advances in genetics in patients with type 2 diabetes and gestational diabetes and how healthcare biobanks can accelerate clinical research.
1. What were your highlights of the 80th ADA 2020 Virtual Scientific Sessions? (0:06)
2. What was your experience organising a virtual conference of this size, and are you pleased with how it has turned out? (1:41)
3. Please summarise the research that you are involved in on genetics in patients with type 2 diabetes and gestational diabetes (3:09)
4. Please provide an overview of the benefits of healthcare biobanks and how they can accelerate clinical research (5:24)
Speaker disclosure: Jose Florez has received one honorarium from Novo Nordisk to speak at a scientific meeting on a topic of his choice.
Support: Interview commissioned and filming supported by Touch Medical Media.
Filmed in coverage of the ADA 2020 Virtual 80th Scientific Sessions
Related Videos In Diabetes
Dr Teresa Quattrin, EASD 2020 – Updates from the T1GER study
We spoke with Teresa Quattrin (University at Buffalo, Oishei Children’s Hospital) following her presentation of the T1GER study, which investigated the effect of treatment with golimumab in children, adolescents, and young adults with newly diagnosed type 1 diabetes. Disclosures: Tersea Quattrin discloses the following: Consultant to Janssen Research & Development Clinical Trial, Principal Investigator at […]
Prof. Hiddo Lambers Heerspink, EASD 2020 – Updates from the DAPA-CKD trial
touchENDOCRINOLOGY were delighted to speak with Prof. Hiddo Lambers Heerspink to hear more about the highly anticipated results of DAPA-CKD, investigating dapagliflozin in patients with chronic kidney disease with or without type 2 diabetes. Disclosures: Prof. Lambers Heerspink discloses the following: Grant Funding and Consultancy from AstraZeneca, Boehringer Ingelheim and AbbVie, Steering committee member for […]
Dr Ramzi Ajjan, EASD 2020 – Updates from the LIBERATES trial
We spoke with Dr Ramzi Ajjan (University of Leeds and Leeds Teaching Hospitals Trust) at Virtual EASD 2020 following the presentation of the results from the LIBERATES trial (improving gLucose control in patIents with diaBEtes following myocaRdial infArction: The role of a novEl glycaemic monitoring). Disclosures: Ramzi Ajjan has received institutional research grants from Abbott, […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!